Core Insights - Catheter Precision, Inc. achieved significant growth in 2025, with a revenue increase of 95% year-over-year, reaching $819 thousand compared to $420 thousand in 2024 [14] - The company expanded its operations by acquiring Flyte, a regional air mobility company, which diversifies its business into aviation alongside its medical device platform [5][6] Financial Performance - For the full year 2025, the company reported a gross margin of 92.3%, up from 90.0% in 2024 [14] - The net loss for 2025 was $17.2 million, with $7.8 million being non-cash, compared to a net loss of $16.6 million in 2024, of which $7.5 million was non-cash [14] - In Q4 2025, revenue was $238 thousand, a 60% increase from $148 thousand in Q4 2024, with a gross margin of 91.6% [14] Operational Highlights - The company made strides in clinical and commercial validation, expanding its customer base and advancing commercialization efforts in Europe [2][3] - The VIVO and LockeT platforms demonstrated clinical value, with 32 new customers added and the first commercial sales of LockeT in Europe [7][8] Strategic Outlook - The acquisition of Flyte positions the company to tap into a rapidly growing market, enhancing its diversified platform across healthcare technology and regional aviation [5][6] - Management believes that the initiatives undertaken create a framework for accelerated growth and potential re-rating as execution milestones are achieved [9]

Core Insights - Flyte has officially launched its regional aviation service, Flyte Hops Florida, expanding its network from New York to cover the entire East Coast from Maine to Florida [1][3][4] - The service generated over $160,000 in inbound flight bookings during a soft launch in Florida, indicating strong organic demand without any marketing efforts [2][4] - Flyte plans to expand its fleet with at least five Cirrus Vision Jets operational by Memorial Day 2026, with future expansions into California and Texas [8] Fleet Expansion and Strategy - Flyte is executing a fleet expansion strategy to replicate its regional air-mobility model across high-demand U.S. markets [8] - The company aims to connect underutilized regional airports, providing a faster alternative to traditional travel by bypassing major hubs [6][8] - Additional markets in the Midwest and Northwest are currently under evaluation for future expansion [9] Market Opportunity - The U.S. has over 5,000 public-use airports, most of which are underutilized by commercial airlines, presenting a significant opportunity for regional aviation platforms like Flyte [7] - The demand for regional air travel is validated by the success of Flyte's trial launch in Florida, which exceeded expectations [4][6]

Core Viewpoint - Catheter Precision, Inc. has announced significant balance sheet improvements through new institutional capital commitments, supporting the growth of its subsidiary Flyte and its expansion strategy in the regional aviation market [1][2][3]. Group 1: Growth Strategy and Capital Support - Flyte, a newly acquired subsidiary, is positioned to execute its expansion strategy with a fully funded growth plan supported by Catheter Precision [2]. - Recent strategic financings have been completed to support the transformation of the company and the expansion of the Flyte aviation platform, which also includes funding for medical device operations [2][3]. - The company believes that with access to significant institutional capital, Flyte is uniquely positioned to expand fleet operations and enter new markets [3][10]. Group 2: Market Opportunity and Operational Foundation - The regional air mobility sector is viewed as a major growth opportunity within the aviation industry, driven by increasing demand for faster regional transportation options [11]. - Flyte aims to address the growing demand for time-efficient regional air mobility, offering premium point-to-point travel between major metropolitan regions and underserved secondary markets [5][10]. - The operational foundation of Flyte allows for rapid fleet growth and expansion into additional high-demand regional markets [6][11]. Group 3: Fleet Expansion and Infrastructure - Flyte operates a growing fleet of certified aircraft and has established route infrastructure across key regional markets [9]. - The company is focused on scaling its aviation platform infrastructure and expanding its market presence across additional regional corridors [8][9]. - The acquisition of Flyte, combined with newly secured institutional capital, provides a foundation for a focused, high-growth aviation strategy while simplifying the company's balance sheet [7][10].

Core Insights - The acquisition of Flyte by Catheter Precision, Inc. (VTAK) transforms it from a minority investment into a wholly owned subsidiary, enhancing VTAK's position in the regional air mobility sector with a scalable, revenue-generating aviation platform [1][2][5] Group 1: Acquisition Details - VTAK has completed the acquisition of an 80.02% equity interest in Flyte, achieving 100% ownership of the AI-enabled regional aviation operator [1] - Flyte operates under FAA 14 CFR Part 135 certification, utilizing Cirrus Vision Jets for high-frequency, short-haul regional routes where commercial airline capacity is limited [3][4] Group 2: Financial Impact - Full ownership allows for the consolidation of Flyte's operations, assets, and financial results into VTAK's statements, providing direct exposure to operating performance and long-term value creation [4] - The acquisition is expected to enhance VTAK's long-term valuation profile by contributing consolidated revenues and asset backing, along with the potential for substantial operating leverage [6] Group 3: Strategic Positioning - The acquisition aligns with VTAK's strategy of investing in businesses with tangible assets and scalable infrastructure, supporting sustainable growth and long-term value creation [5][7] - Flyte's operational model emphasizes capital efficiency and high aircraft utilization, positioning it well for disciplined expansion in response to market demand [7][9] Group 4: Market Opportunities - Flyte operates in short-haul corridors targeted by future advanced air mobility and electric aircraft developers, generating real operating data and customer engagement while maintaining flexibility for future industry evolution [11][12] - The structure allows VTAK to engage in regional air mobility growth without relying on extended certification timelines, combining current revenue generation with future strategic options [12]

Core Insights - Creatd, Inc. has sold its remaining 80% equity stake in Fly Flyte, Inc. to Catheter Precision, Inc. for approximately $6 million in cash and nearly $6 million in Convertible Preferred Stock, significantly strengthening its balance sheet [1][2][5] Group 1: Transaction Details - The sale aligns with Creatd's strategy of developing turnkey operating solutions for businesses preparing for public market listings while retaining a minority interest [2] - The transaction positions Creatd as a significant shareholder in VTAK, enhancing its portfolio of public and private positions across various industries [3] - Creatd's acquisition of Flyte was completed approximately one year ago, with a disciplined turnaround strategy focused on operational optimization and revenue growth [4] Group 2: Future Plans and Strategy - Creatd plans to pursue its own national exchange listing strategy this year without relying on traditional financing structures [6] - The recent asset sale provides the necessary capital to complete the next phase of its growth strategy, which includes acquisition and incubation strategies for exchange-listed entities [6] - The company aims to address the structural gap in the middle market, helping public companies stabilize and scale to reach national exchange listings [7] Group 3: Company Overview - Creatd, Inc. focuses on acquiring and growing technology-driven companies in sectors such as aviation, media, and advisory services [8] - Flyte operates a fleet of Cirrus Vision Jets, providing a faster and more efficient alternative to traditional private charter services [9] - Flyte is building a disciplined, asset-backed aviation infrastructure designed to serve underserved regional markets [10]

Core Insights - Catheter Precision, Inc. has made a strategic minority investment in Fly Flyte, Inc., a regional aviation operator, to gain immediate exposure to a revenue-generating, asset-backed business in the air mobility sector [1][10] Investment Overview - The investment allows Catheter Precision to acquire a 19.98% equity ownership in Flyte, providing access to one of the fastest-growing segments of private aviation [7] - Flyte operates under FAA certification and is currently generating revenue with its fleet of Cirrus Vision Jets, which are equipped with advanced safety features [2][8] Strategic Positioning - Flyte is positioned to benefit from the anticipated future commercialization of electric vertical takeoff and landing (eVTOL) aircraft, operating in the same corridors targeted for future electric aircraft integration [5][6] - The company leverages certified aircraft and established infrastructure to generate active revenue and customer engagement, which is crucial for long-term capital investment [6][9] Operational Efficiency - Flyte employs AI-enabled optimization across various operational aspects, including routing, pricing, and dispatch, contributing to a capital-efficient growth model [8] - The company maintains a disciplined approach to expansion, targeting scalable revenue growth while preserving capital efficiency [4][11] Long-Term Value Creation - The investment reflects a broader strategy of Catheter Precision to deploy capital into businesses with scalable infrastructure and clear paths to long-term value creation [10][16] - Flyte's model is designed for disciplined execution and measured growth, positioning it well for the evolving regional air mobility landscape [11]

Core Insights - Creatd, Inc.'s aviation subsidiary, Flyte, is positioned for expansion following Verijet's Chapter 7 bankruptcy, highlighting the risks of overextension in the private aviation market [1][6] - Flyte aims to strategically strengthen its presence in key markets by integrating valuable assets from Verijet's liquidation [2][4] Company Strategy - Flyte was designed to scale the charter business while maintaining operational integrity, learning from the mistakes of others in the industry [2][3] - The company plans to absorb valuable assets such as aircraft, routes, and talent from Verijet to enhance its operations [4][6] Market Context - Verijet's failure serves as a lesson that unsustainable growth without stability can lead to collapse, emphasizing the need for disciplined growth in the aviation sector [4][6] - The private aviation sector is experiencing volatility, creating new opportunities for disciplined operators like Flyte [6] Leadership Vision - CEO Jeremy Frommer emphasizes the importance of balancing vision with financial reality, stating that the next generation of aviation companies must build sustainable models [5][6] - Flyte's approach focuses on steady growth across its three divisions: Flyte Luxe, Flyte Hops, and Flyte Escapes, each targeting distinct market segments [4][6]